The Efficacy and Safety of Irinotecan, Paclitaxel and Oxaliplatin (IPO) Regimen as Salvage in Relapsed/Refractory Ovarian Germ Cell Tumors

被引：0
|
作者：
Sivasree Kesana
Perumal Kalaiyarasi Jayachandran
Gangothri Selvarajan
Subramaniam Murali Carthikeyan
Venkatraman Radhakrishnan
Tenali Gnana Sagar
Trivadi Sundaram Ganesan
机构：
[1] Cancer Institute (W.I.A),Department of Medical Oncology
[2] Cancer Institute (WIA),Department of Medical Oncology
来源：
Indian Journal of Gynecologic Oncology | 2023年 / 21卷
关键词：
Ovarian GCT; Relapsed/Refractory ovarian germ cell tumor; Salvage chemotherapy; Irinotecan; Paclitaxel and Oxaliplatin (IPO); Cisplatin ineligible Ovarian GCT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The Efficacy and Safety of Irinotecan, Paclitaxel and Oxaliplatin (IPO) Regimen as Salvage in Relapsed/Refractory Ovarian Germ Cell Tumors
    Kesana, Sivasree
    Jayachandran, Perumal Kalaiyarasi
    Selvarajan, Gangothri
    Carthikeyan, Subramaniam Murali
    Radhakrishnan, Venkatraman
    Sagar, Tenali Gnana
    Ganesan, Trivadi Sundaram
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 21 (01)
  • [2] The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours: A non-cisplatin-based regimen
    Badreldin, Waleed
    Chowdhury, Simon
    Harland, Stephen John
    Mazhar, Danish
    Powles, Thomas
    Wilson, Peter
    Shamash, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] A phase II study of irinotecan, paclitaxel and oxaliplatin (IPO) in patients with multiply relapsed germ cell tumours (GCT).
    Shamash, J
    Powles, T
    Mutsangwa, K
    Cotton, L
    Oliver, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 384S - 384S
  • [4] Efficacy of Gemcitabine, Paclitaxel, and Oxaliplatin Protocol in the Treatment of Relapsed or Refractory Germ Cell Tumours
    Aykan, Musa Baris
    Yildiran, Gul Sema
    Akcan, Ece
    Acar, Ramazan
    Erturk, Ismail
    Karadurmus, Nuri
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (07): : 880 - 884
  • [5] Gemcitabine, paclitaxel, and oxaliplatin (GEMPOX) in the treatment of relapsed/refractory intracranial nongerminomatous germ cell tumors
    Perez-Somarriba, Marta
    Luisa Moreno-Tejero, Maria
    Isabel Rozas, Maria
    Pelaez, Irene
    Madero, Luis
    Lassaletta, Alvaro
    PEDIATRIC BLOOD & CANCER, 2020, 67 (02)
  • [6] Salvage Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin (TIP) in Relapsed or Cisplatin-Refractory Germ Cell Tumors
    Park, Silvia
    Lee, Soohyeon
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Kang, Won Ki
    Park, Young Suk
    Lim, Ho Yeong
    ONKOLOGIE, 2011, 34 (8-9): : 416 - 420
  • [7] Salvage chemotherapy with irinotecan and nedaplatin for cisplatin refractory germ cell tumors
    Nakamura, T.
    Nonomura, N.
    Mikami, K.
    Shiraishi, T.
    Takaha, N.
    Okuyama, A.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach
    Badreldin, Waleed
    Krell, Jonathan
    Chowdhury, Simon
    Harland, Stephen J.
    Mazhar, Danish
    Harding, Victoria
    Frampton, Adam E.
    Wilson, Peter
    Berney, Daniel
    Stebbing, Justin
    Shamash, Jonathan
    BJU INTERNATIONAL, 2016, 117 (03) : 418 - 423
  • [9] Combination chemotherapy with gemcitabine, oxaliplatin and paclitaxel in patients with cisplatin-refractory or relapsed germ cell tumors (gct)
    Oechsle, K.
    Bokemeyer, C.
    Honecker, F.
    Mayer, F.
    Waller, C. F.
    Boehlke, I.
    Hartmann, J. T.
    Kollmannsberger, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Paclitaxel chemotherapy in the salvage of multiply relapsed and platinum refractory germ cell tumours
    Staffurth, JN
    Nichols, J
    Huddart, RA
    Dearnaley, DP
    Horwich, A
    BRITISH JOURNAL OF CANCER, 2000, 83 : 77 - 77
12345